(Q48405370)

11 February 2018

title

Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia. (English)

1 reference

11 February 2018

0 references

1 reference

1 reference

O'Neill MJ

1

1 reference

11 February 2018

Hicks CA

2

1 reference

11 February 2018

Ward MA

3

1 reference

11 February 2018

Cardwell GP

4

1 reference

11 February 2018

Reymann JM

5

1 reference

11 February 2018

Allain H

6

1 reference

11 February 2018

Bentué-Ferrer D

7

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

11 February 2018

European Journal of Pharmacology

published in

1 reference

11 February 2018

volume

352

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

37-46

1 reference

11 February 2018

Changes in extracellular concentrations of glutamate, aspartate, glycine, dopamine, serotonin, and dopamine metabolites after transient global ischemia in the rabbit brain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

L-type voltage-dependent calcium channels do not modulate aminergic neurotransmitter release induced by transient global cerebral ischaemia: an in vivo microdialysis study in rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Temporal profile of aminergic neurotransmitter release in striatal dialysates in rats with post-ischemic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Direct evidence of acute, massive striatal dopamine release in gerbils with unilateral strokes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Lesioning the substantia nigra reduces striatal infarct volume following focal ischemia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Neuroprotective effect of the AMPA receptor antagonist LY-293558 in focal cerebral ischemia in the cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

The dopamine agonists lisuride and piribedil protect against behavioural and histological changes following 4-vessel occlusion in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Lisuride prevents learning and memory impairment and attenuates the increase in extracellular dopamine induced by transient global cerebral ischemia in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

7 January 2021

Excitotoxic cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Lazaroids. CNS pharmacology and current research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Dopamine depletion protects striatal neurons from ischemia-induced cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

The antioxidant LY231617 reduces global ischemic neuronal injury in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

The effect of pergolide and MDL 72974 on rat brain CuZn superoxide dismutase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Effects of transient forebrain ischemia and pargyline on extracellular concentrations of dopamine, serotonin, and their metabolites in the rat striatum as determined by in vivo microdialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Substantia nigra lesion protects against ischemic damage in the striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Protective effects of brain hypothermia on behavior and histopathology following global cerebral ischemia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Inhibition of lipid peroxidation in central nervous system trauma and ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Dopamine has inhibitory and accelerating effects on ischemia-induced neuronal cell damage in the rat striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

New insights into the cause of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Neuronal apoptosis: current understanding of molecular mechanisms and potential role in ischemic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Bromocriptine protects against delayed neuronal death of hippocampal neurons following cerebral ischemia in the gerbil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Alpha-methyl-para-tyrosine pretreatment protects from striatal neuronal death induced by four-vessel occlusion in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Scavenging effects of dopamine agonists on nitric oxide radicals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Neuroprotective effects of 7-nitroindazole in the gerbil model of global cerebral ischaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Effects of transient, global, cerebral ischemia on striatal extracellular dopamine, serotonin and their metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Neuroprotective properties of 5-HT1A receptor agonists in rodent models of focal and global cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Effects of serotonergic drugs in experimental brain ischemia: evidence for a protective role of serotonin in cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Extracellular dopamine and serotonin in the rat striatum during transient ischaemia of different severities: a microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Effect of global ischaemia, under simulated penumbral conditions, on brain monoamine neurochemistry and subsequent neurological and histological deficits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Neuroprotective effects of the dopamine agonists pramipexole and bromocriptine in 3-acetylpyridine-treated rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Recombinant human superoxide dismutase can attenuate ischemic neuronal damage in gerbils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Reduction of dopamine synthesis inhibition by dopamine autoreceptor activation in striatal synaptosomes with in vivo reserpine administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Postischemic, systemic administration of polyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Immediate or delayed mild hypothermia prevents focal cerebral infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Free radicals and their scavengers in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

Antioxidant properties of bromocriptine, a dopamine agonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900333-1

10.1016/S0014-2999(98)00333-1

7 January 2021

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018